Ingevity (NGVT)
(Delayed Data from NYSE)
$38.44 USD
+1.94 (5.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $38.46 +0.02 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for Ingevity Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -5.40 | 211.60 | 118.10 | 181.40 | 183.70 |
Depreciation/Amortization & Depletion | 122.80 | 108.80 | 109.90 | 100.20 | 85.00 |
Net Change from Assets/Liabilities | -162.70 | -66.80 | 21.60 | 8.70 | -35.30 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 250.40 | 59.50 | 43.40 | 62.10 | 42.30 |
Net Cash From Operating Activities | 205.10 | 313.10 | 293.00 | 352.40 | 275.70 |
Property & Equipment | -109.80 | -142.50 | -103.80 | -82.10 | -114.80 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -344.50 | 0.00 | 0.00 | -537.90 |
Investments | 29.10 | -77.40 | -35.30 | -2.00 | -2.00 |
Other Investing Activities | 3.40 | 10.50 | -1.50 | -26.50 | -3.60 |
Net Cash from Investing Activities | -77.30 | -553.90 | -140.60 | -110.60 | -658.30 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -92.10 | -145.20 | -109.40 | -88.00 | -6.40 |
Issuance (Repayment) of Debt | -7.30 | 199.00 | -24.10 | 52.80 | 383.80 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -1.90 | -4.40 | 2.10 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.50 | -5.70 | 2.30 | -10.60 | -10.30 |
Net Cash from Financing Activities | -99.90 | 48.10 | -133.10 | -50.20 | 369.20 |
Effect of Exchange Rate Changes | -0.30 | -6.00 | -1.70 | 2.20 | 0.20 |
Net Change In Cash & Equivalents | 27.60 | -198.70 | 17.60 | 193.80 | -13.20 |
Cash at Beginning of Period | 84.30 | 276.00 | 258.40 | 64.60 | 77.80 |
Cash at End of Period | 111.90 | 77.30 | 276.00 | 258.40 | 64.60 |
Diluted Net EPS | -0.15 | 5.50 | 2.95 | 4.37 | 4.35 |
Fiscal Year End for Ingevity Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -339.70 | -56.00 | -5.40 | 111.40 | 86.20 |
Depreciation/Amortization & Depletion | 406.00 | 29.60 | 122.80 | 97.70 | 62.50 |
Net Change from Assets/Liabilities | -65.50 | -43.10 | -162.70 | -139.10 | -151.50 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 16.80 | 57.40 | 250.40 | 90.50 | 56.40 |
Net Cash From Operating Activities | 17.60 | -12.10 | 205.10 | 160.50 | 53.60 |
Property & Equipment | -34.70 | -16.60 | -109.80 | -80.60 | -47.10 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 29.10 | 29.10 | 31.40 |
Other Investing Activities | 0.60 | 0.30 | 3.40 | -4.80 | -5.80 |
Net Cash from Investing Activities | -34.10 | -16.30 | -77.30 | -56.30 | -21.50 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | -92.10 | -92.10 | -92.10 |
Issuance (Repayment) of Debt | 36.50 | 26.00 | -7.30 | -3.60 | 52.50 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 2.40 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.80 | -2.60 | -0.50 | -0.10 | -0.50 |
Net Cash from Financing Activities | 33.70 | 23.40 | -99.90 | -93.40 | -40.10 |
Effect of Exchange Rate Changes | -3.80 | -1.80 | -0.30 | -3.00 | -0.70 |
Net Change In Cash & Equivalents | 13.40 | -6.80 | 27.60 | 7.80 | -8.70 |
Cash at Beginning of Period | 111.90 | 111.90 | 84.30 | 77.30 | 77.30 |
Cash at End of Period | 125.30 | 105.10 | 111.90 | 85.10 | 68.60 |
Diluted Net EPS | -7.81 | -1.54 | -3.16 | 0.69 | 0.97 |